SEC Tracker
Get the app

Graphite Bio LENZ

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
Exhibit 10.4
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Graphite Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. ImmunityBio IBRX public float $690M, Jun 30, 2025
  2. Vir Biotechnology VIR public float $689M, Jun 30, 2025
  3. Anavex Life Sciences AVXL public float $708M, Mar 31, 2025, over 18 months old
  4. Relay Therapeutics RLAY public float $586M, Jun 30, 2025
  5. Ginkgo Bioworks Holdings DNA public float $553M, Jun 28, 2025